Summary
Matthew Brewer is a life sciences executive and entrepreneur with 12 years of leadership experience building and commercializing therapeutic and data-driven healthcare ventures from Boulder, Colorado. As CEO of HAVAH Therapeutics he is driving a landmark phase 2 clinical program to prevent progression of hormonally driven breast disease, and his track record includes founding and steering companies that license, develop, and spin out biologics and data platforms for clinical and commercial impact. He combines deal-making and operational turnaround experience—from leading BaroFold through acquisition and licensing to founding Betterpath to transform unstructured health data—alongside venture and corporate development roles at Intrexon and Covalent Data. Known for pragmatic commercialization strategies, he repeatedly aligns scientific teams, investors, and partners to advance assets into clinical studies and strategic exits. An MBA from Kellogg and a background in political science inform his structured approach to negotiation, governance, and stakeholder engagement. Notably, he has taken principled stands in tech ecosystems, migrating code hosting in protest of corporate actions, reflecting a values-driven leadership style.
12 years of coding experience
14 years of employment as a software developer
Bachelor of Arts - BA, Political Science and Government, Bachelor of Arts - BA, Political Science and Government at University of Oregon
Kellogg School of Management
French